Ratio of CC50 for Huntington's disease patient derived fibroblasts to IC50 for HSP90 in HEK cells expressing full-length mHtt Q73 gene assessed as red...

Basic Information

ID: ALA3242277

Type: Unassigned

Description: Ratio of CC50 for Huntington's disease patient derived fibroblasts to IC50 for HSP90 in HEK cells expressing full-length mHtt Q73 gene assessed as reduction of mHtt level

Format: BAO_0000219

Organism: Homo sapiens

Cell type: HEK293

Target: Unchecked(ALA612545)

Document: ALA3232825

Ratio of CC50 for Huntington's disease patient derived fibroblasts to IC50 for HSP90 in HEK cells expressing full-length mHtt Q73 gene assessed as reduction of mHtt level: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3242277

Ratio CC50/IC50

Total(2)

Parent Molecular Weight	ALogP	Polar Surface Area
399.47	3.38	3.38
390.53	4.88	4.88

Parent Molecular Weight

ALogP

Polar Surface Area

399.47

3.38

390.53

4.88

Ratio of CC50 for Huntington's disease patient derived fibroblasts to IC50 for HSP90 in HEK cells expressing full-length mHtt Q73 gene assessed as red...

Basic Information

Activity Charts

Compound Summary